Wed, Nov 04, 2026 - Page 101
24697 indexed SquawkNews stories from this UTC day. Showing 12001-12120.
L
Viatris announces quarterly dividend per share
Viatris announced a quarterly dividend per share.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Four Firms Selected for South Korean Government Maritime Connectivity Project
ST Engineering iDirect, KT SAT, Waldo and Intellian were selected to advance secure maritime connectivity for a South Korean government project.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Pixelworks Q3'26 Earnings Preview: Revenue Estimated at 300.00K USD
Pixelworks is scheduled to report Q3'26 results on November 11 after the market closes. Revenue is estimated at 300.00K USD, with EPS anticipated at (0.26) USD.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
IREN Q1'27 Earnings Preview
IREN is scheduled to report Q1'27 results on November 5 after the market closes. The source describes revenue and EPS estimates but provides no supported numeric values for them.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Paylocity Q1'27 Earnings Preview
Paylocity is scheduled to report Q1'27 results on November 5 after the market close.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Adicet Bio Q3 Results Scheduled for November 11
Adicet Bio is scheduled to report Q3 results on November 11. Revenue is estimated at zero, with EPS anticipated at negative 1.58.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
AC Immune files Form 6-K
AC Immune filed a Form 6-K on November 4.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Protagonist Therapeutics Q3'26 Earnings Preview
The company is scheduled to report Q3'26 results on November 5. The release time is not specified.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Solnul Study Replicates Microbiome and Digestive Comfort Outcomes
A new study reportedly replicated Solnul’s bifidogenic effect, stool form outcomes and tolerability.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Arcline-Backed Signia Aerospace to Acquire Heads Up Technologies
Signia Aerospace says it will acquire Heads Up Technologies, expanding its aircraft cabin systems capabilities.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Brink's Reports $15M Third-Quarter Net Income
EARNINGS | Nov 04, 2026, 12:03 PM UTC
M
ImageneBio Q3'26 Results Preview
ImageneBio is expected to report Q3'26 results on November 11; the release time is unspecified. EPS is anticipated at $(0.80).
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Brink's Reports Third-Quarter Revenue of $1.38B
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Graphic Packaging Offers Boardio Paperboard Canister to Nutraceutical Brands
Graphic Packaging says its Boardio paperboard canister is now available to North American nutraceutical brands via Combined Technologies.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Nova Ltd. Q3'26 Earnings Preview
Nova Ltd. is set to report Q3'26 results on November 5 before the market opens.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Cushman & Wakefield Reports Third-Quarter 2026 Results
Diluted EPS was $0.22, flat year over year, while adjusted EPS rose 28% to $0.37.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
WMS Q2'26 Earnings Preview: EPS Estimated
Advanced Drainage Systems is set to report Q2'26 results on November 5 before the market opens. Revenue and EPS estimates were provided.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Viatris Announces a Quarterly Dividend
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Insulet Reports Third-Quarter 2026 Revenue of $842 Million, Up 19.2%
Insulet reported third-quarter revenue of $842 million, an increase of 19.2% year over year, or 19.6% in constant currency.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
SCYNEXIS Q3'26 Revenue Estimate
A preview gives Q3'26 revenue and EPS estimates; results are scheduled for November 11, with the release time unspecified.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Enanta Pharmaceuticals to Participate in Upcoming Investor Conferences
Enanta said members of management will participate in upcoming investor conferences; a live webcast will be available.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Verano Opens MÜV Dispensary in Fernandina Beach, Florida
The opening brings Verano's Florida retail footprint to 87 locations.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Brink's Co Reports Third-Quarter EPS
EARNINGS | Nov 04, 2026, 12:03 PM UTC
L
Treasury Refunding Details Due as Five Companies Report Higher Revenue
U.S. stock index futures were mixed, according to the supplied commentary.
MACRO | Nov 04, 2026, 12:03 PM UTC
M
Annovis Bio Q3'26 Results Scheduled for Nov. 11
Annovis Bio is scheduled to report Q3'26 results on Nov. 11. Revenue is estimated at zero; EPS is anticipated at $(0.30). The release time is unspecified.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
DraftKings Q3 Earnings Preview: EPS Estimate
DraftKings is scheduled to report Q3 results after the market closes on November 5. Revenue and EPS estimates are provided in the source.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
VVT Med Signs Poland Deal Targeting CAD$1.42 Million in Sales
VVT Med announced a Poland deal targeting CAD$1.42 million in sales, citing more than 1,000 ScleroSafe procedures and established clinical experience in the country.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Aircastle Announces End to Voluntary SEC Reporting
Aircastle said it is transitioning from voluntary SEC reporting.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Innoviz Q3'26 Revenue Estimate Set at 19.00M USD
Innoviz Technologies is scheduled to report Q3'26 results on November 11 before the market opens. Revenue is estimated at 19.00 million USD and EPS at (0.07) USD.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Brink's Co Reports Third-Quarter Adjusted EPS of $2.46
EARNINGS | Nov 04, 2026, 12:03 PM UTC
M
Vertical Aerospace Q3 Results Scheduled for Nov. 11
Vertical Aerospace is scheduled to report Q3 results on Nov. 11. The supplied preview estimates revenue at zero and EPS at negative 0.33; the release time is not specified.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Corero Network Security Appoints Regional Leaders to Strengthen EMEA and APAC Operations
Corero says new leadership appointments will strengthen its EMEA and APAC operations.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Bioxytran Secures Free Sale Certification for A-SUQAR®
The certification opens a path to the UAE and Gulf markets for the chewable nutraceutical.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Arrow Electronics Q3'26 Results Expected November 5
Arrow Electronics is scheduled to report Q3'26 results before the market opens on November 5.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
ZSTK Q3'26 Earnings Preview: Revenue Estimate
ZeroStack Corp. is scheduled to report Q3'26 results on November 11. Revenue and EPS estimates were provided; the announcement time is not specified.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
MiNK Therapeutics Q3'26 Earnings Preview Lists Revenue Estimate
MiNK Therapeutics is scheduled to report Q3'26 results November 11 before the market opens. Revenue is estimated at 875.00K USD and EPS at (0.50) USD.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
ViaSat Q2'26 Earnings Preview: EPS Estimated at (0.42) USD
ViaSat is scheduled to report Q2'26 results on November 5 after the market close. Revenue is estimated at 1.20 billion USD, with EPS anticipated at (0.42) USD.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
SharkNinja Reports Third-Quarter Sales of $1.98 Billion
EARNINGS | Nov 04, 2026, 12:03 PM UTC
L
Operation Healing Forces Marks 15 Years With $15,000 Matching Gift Campaign
Raymond James supports a $15,000 matching gift campaign for Operation Healing Forces’ 15th anniversary.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
GMED Q3'26 Results Due November 5
Globus Medical is scheduled to report Q3'26 results after the market close on November 5.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
FROG Q3'26 Results Due November 05; EPS Estimated at 0.23 USD
JFrog is scheduled to report Q3'26 results after the market closes on November 05. Revenue is estimated at 165.92 million USD and EPS at 0.23 USD.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Madison Air Solutions Q3 Earnings Preview
Madison Air Solutions is scheduled to report Q3'26 results on November 5 before the market opens, with results expected at 9:30 a.m. ET (2:30 p.m. UTC).
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
NFE Q3'26 Earnings Preview
NFE is scheduled to report Q3'26 results on November 11; the report time is unspecified. Revenue and EPS estimates were provided.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Genprex Announces Research on TROP2 Biomarker for Reqorsa Gene Therapy
The company says the research links TROP2 expression to treatment response in lung cancer and will be presented at the 2026 EORTC-NCI-AACR Symposium.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Kensing Unveils Sunflower Sterol-Enriched Cream Cheese
Kensing unveiled cream cheese enriched with sunflower sterols. The body says Sunvasterol™ EST delivers EFSA-recognised cholesterol-lowering benefits to spreads, yogurts, and other products, but is truncated.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Tenaya Therapeutics Q3'26 Earnings Preview
Tenaya Therapeutics is scheduled to report Q3'26 results on November 11. Revenue and EPS estimates were provided.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
COYA Q3'26 Revenue Estimate Ahead of Results
COYA is set to report Q3'26 results on November 11; revenue and EPS estimates were provided. The release time is unspecified.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
AHR Q3 Results Expected November 5
American Healthcare REIT is scheduled to report Q3'26 results after the market closes on November 5.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
OPENLANE Reports Third-Quarter 2026 Financial Results
Marketplace commercial vehicles sold grew 46% year over year; marketplace dealer vehicles sold growth was reported.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Empower Brands Proposes to Acquire Helen of Troy for $37 Per Share
Empower Brands proposed an all-cash acquisition of Helen of Troy at $37 per share. The proposal represents a 31% premium over HELE’s 30-day volume-weighted average price, according to the headline and available body text
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
SharkNinja Reports Third-Quarter Adjusted EPS of $2.34
EARNINGS | Nov 04, 2026, 12:03 PM UTC
M
FNF Q3'26 Earnings Preview
Fidelity National Financial is scheduled to report Q3'26 results on November 5 after the market close.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Flutter Entertainment files Form 10-Q for quarter ended September 30
Flutter Entertainment filed its Form 10-Q on November 4. The filing covers the period ended September 30.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Odyssey Therapeutics Reports Third-Quarter 2026 Results and Clinical Update
The company said additional analyses from the Phase 2a induction period for OD-001 further strengthen clinical proof.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
DISA Uranium Hosts Leaders at First NRC-Licensed Colorado Cleanup Project
The Mary Ann project demonstrates the potential to address legacy abandoned uranium mine waste.
ENERGY | Nov 04, 2026, 12:03 PM UTC
M
Texas Roadhouse Q3'26 Earnings Preview: EPS Estimate at 1.46 USD
Texas Roadhouse is scheduled to report Q3'26 results on November 05 after the market closes. Revenue is estimated at 1.58 billion USD; EPS at 1.46 USD.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Nkarta Q3 Earnings Preview: Revenue Estimated at Zero
Nkarta is expected to report Q3 results on November 11. Revenue is estimated at zero and EPS at negative 0.40; the release time is not specified.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Royalty Pharma Reports Third-Quarter 2026 Results
Portfolio Receipts grew 9% to $890 million; Royalty Receipts also grew 9%.
EQUITY | Nov 04, 2026, 12:03 PM UTC
M
Akamai Q3 Earnings Preview: Estimates Ahead of Scheduled Results
Akamai is scheduled to report Q3'26 results on November 5 after the market closes. Revenue and EPS estimates were provided, but their numeric values are omitted here.
EQUITY | Nov 04, 2026, 12:03 PM UTC
L
Four Companies Selected for South Korean Government Maritime Connectivity Project
ST Engineering iDirect, KT SAT, Waldo and Intellian were selected to advance secure maritime connectivity for a South Korean government project.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Frontier Medicines to Present Preclinical FMC-242 Data at Cancer Symposium
The company says preclinical data showed enhanced anti-tumor activity and tumor regression with FMC-242.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Enanta Pharmaceuticals to Participate in Investor Conferences
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Bentley Systems Q3'26 Earnings Preview Includes EPS Estimate
Bentley Systems is scheduled to report Q3'26 results on November 5 before the market opens. Revenue and EPS estimates were provided ahead of the report.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
SharkNinja Reports Third-Quarter Net Income of $338.4 Million
EARNINGS | Nov 04, 2026, 12:02 PM UTC
M
Greystone Housing Impact Investors Q3'26 earnings preview
The company is scheduled to report Q3'26 results on November 11; results are expected at 7:00 AM ET (12:00 PM UTC).
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Regency Centers Q3 Earnings Preview
Regency Centers is scheduled to report Q3'26 results on November 5 after the market closes. Revenue and EPS estimates were provided.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Corero Network Security Appoints Regional Leaders to Support International Growth
Corero says new leadership appointments will strengthen its EMEA and APAC operations and support international growth.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Charles River Laboratories Reports Third-Quarter 2026 Results
Revenue was $982.7 million, down 2.2% from $1,004.9 million in the third quarter of 2025.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
SharkNinja Reports Third-Quarter EPS of $2.39
EARNINGS | Nov 04, 2026, 12:02 PM UTC
L
Wayfair reports third-quarter adjusted EPS
EARNINGS | Nov 04, 2026, 12:02 PM UTC
L
Flutter Entertainment Amends Credit Agreement
Flutter Entertainment entered into a first amendment to its credit agreement on Oct. 30, 2026, according to an SEC filing.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Wayfair reports third-quarter net income of $62 million
EARNINGS | Nov 04, 2026, 12:02 PM UTC
M
Camden Property Trust Q3 Earnings Preview
Camden Property Trust is scheduled to report Q3'26 results November 5 after the market close.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Minerva Neurosciences Q3'26 Results Scheduled for Nov. 11
Minerva Neurosciences is scheduled to report Q3'26 results on November 11; the release time is not specified. Revenue and EPS estimates are provided in the source.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
SharkNinja Sees FY Adjusted EPS of $6.65-$6.75
EARNINGS | Nov 04, 2026, 12:02 PM UTC
L
Sironax Says Two SIR4156 Abstracts Selected for ObesityWeek 2026
Sironax said two abstracts on its NAMPT activator SIR4156 were selected for presentation at ObesityWeek 2026.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
De Nora Reports 9-Month Adjusted Organic EBITDA of €127.1 Million
EARNINGS | Nov 04, 2026, 12:02 PM UTC
L
Ternium Raises Usiminas Lawsuit Provision to $619.1 Million
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
PolyPid Q3 Earnings Preview Includes 30.00M USD Revenue Estimate
PolyPid is scheduled to report Q3 results on November 11 before the market opens. Revenue is estimated at 30.00 million USD, with EPS anticipated at 0.91 USD.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
IonQ Q3'26 Earnings Preview: Revenue, EPS Estimates
IonQ is scheduled to report Q3'26 results on Nov. 5 after the market closes. Revenue and EPS estimates were provided, but their values are omitted here.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Wayfair reports third-quarter EPS
EARNINGS | Nov 04, 2026, 12:02 PM UTC
L
Survey Finds Authority Gap for Senior Living Clinical Leaders
A survey by August Health and ASHA found that only 21% of clinical leaders say their authority fully aligns with their responsibilities.
MACRO | Nov 04, 2026, 12:02 PM UTC
M
Journey Medical Q3'26 Earnings Preview
Journey Medical is scheduled to report Q3'26 results on November 11; the release time is not specified. EPS is anticipated at $(0.02).
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Solventum Q3'26 earnings preview
Solventum is scheduled to report Q3'26 results November 5 after the market close. Revenue and EPS estimates were provided ahead of the release.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Millicom Q3'26 Earnings Preview: EPS and Revenue Estimates
Millicom is scheduled to report Q3'26 results on November 5 before the market opens. Revenue and EPS estimates were provided.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Rate and Compass Combine Joint Ventures to Create OriginPoint
Rate and Compass International Holdings are combining their two joint ventures, creating OriginPoint, described as a top 10 U.S. retail lending leader.
MNA | Nov 04, 2026, 12:02 PM UTC
L
Rouge Care Launches the G5 Series, Its Next Generation of Red Light Therapy
Eight research-backed wavelengths, a redesigned app and four panel sizes arrive just in time for the
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
EuroDry Q3'26 Revenue Estimate Ahead of Q3'26 Results
EuroDry is scheduled to announce Q3'26 results on November 11. Revenue and EPS estimates were provided.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Compass Therapeutics Q3 Earnings Preview: Revenue Estimated at Zero
Compass Therapeutics is scheduled to report Q3 results on November 11. Revenue is estimated at zero, with EPS anticipated at negative 0.13; the release time is not specified.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Carlyle Q3 Earnings Preview
Carlyle is scheduled to report Q3'26 results November 5 before the market opens. The source provides estimates for revenue and EPS.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Wayfair Reports Third-Quarter Revenue of $3.4 Billion
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
McDonald's Third-Quarter Global Comparable Sales Rise 1.5%
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
TA’ZIZ Terminal to Serve Chemicals Zone as Primary Logistics Gateway
ADMO says the TA’ZIZ Terminal project will serve as the primary logistics gateway for the TA’ZIZ industrial chemicals zone.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Wayfair Reports 11M Orders Delivered in Q3
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
JHX Q2'26 Earnings Preview
James Hardie Industries is set to report Q2'26 results on November 5 before the market opens.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
McDonald’s Q3 results include $56 million in pretax restructuring charges
The charges equal $0.06 per share.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Sutro Biopharma Q3'26 Revenue Estimate Is Reported
Sutro Biopharma is scheduled to report Q3'26 results on November 11. Revenue and EPS estimates are provided; the report time is unspecified.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
MoonLake Reports Third-Quarter 2026 Results and Business Update
MoonLake Immunotherapeutics reported third-quarter 2026 financial results and provided a business update.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Kensing Unveils Cream Cheese Enriched With Sunflower Sterols
Kensing unveiled cream cheese enriched with sunflower sterols.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Amplify Energy Q3'26 Revenue Estimate: 43.73M USD
Amplify Energy is scheduled to report Q3'26 results on November 11. EPS is anticipated at 0.03 USD; the release time is not specified.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
United Therapeutics Announces Ralinepag Royalty Buydown
The transaction eliminates the double-digit royalty payable to Pfizer on net sales of ralinepag.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Halozyme Q3'26 Results Expected November 5
Halozyme Therapeutics is scheduled to report Q3'26 results after the market closes on November 5. Revenue and EPS estimates were provided.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Palmer Square Capital BDC Announces Third-Quarter 2026 Results
The company also declared a fourth-quarter 2026 base dividend of $0.36 per share; a supplemental dividend is expected, but its amount is not stated.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
BlossomHill Therapeutics Announces Upcoming Presentation for BH-30236 at ASH
BlossomHill Therapeutics says BH-30236, an oral macrocyclic CLK inhibitor, will be presented at the 68th American Society of Hematology Annual Meeting.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
CuriosityStream Q3'26 Earnings Preview
CuriosityStream is scheduled to report Q3'26 results on November 11 after the market closes. Revenue and EPS estimates were provided.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Insmed to Present at November and December 2026 Investor Conferences
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
De Nora Reports 9M Adjusted Organic EBITDA of €127.1 Million
EARNINGS | Nov 04, 2026, 12:02 PM UTC
L
Swisslog Healthcare Powers Pharmacy Automation at Hospital Israelita Albert Einstein
Swisslog Healthcare has a 12-year partnership with Hospital Israelita Albert Einstein to advance pharmacy automation.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Wayfair reports 22.2M active customers in 3Q
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Sapphiros and binx health Combine to Form Onvaro
The combination forms a diagnostics company named Onvaro.
MNA | Nov 04, 2026, 12:02 PM UTC
M
Sprott Announces Third Quarter 2026 Results
EARNINGS | Nov 04, 2026, 12:02 PM UTC
M
Sionna Therapeutics Q3 Earnings Preview
Sionna Therapeutics is scheduled to report Q3 results on November 11. Revenue is estimated at zero, with EPS anticipated at (0.64) USD.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Lamar Advertising Q3'26 Earnings Preview
Lamar Advertising is scheduled to report Q3'26 results on November 5 before the market opens. Revenue and EPS estimates are provided in the source.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
Valens Semiconductor Q3 Revenue Estimate Is 21.50M USD
Valens Semiconductor is scheduled to report Q3'26 results on November 11 before the market opens. Revenue is estimated at 21.50 million USD, with EPS anticipated at (0.02) USD.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Assured Guaranty Declares Quarterly Dividend of $0.38 Per Share
Assured Guaranty Ltd. declared a quarterly dividend of $0.38 per common share.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Rouge Care Launches the G5 Series, Its Next Generation of Red Light Therapy
Eight research-backed wavelengths, a redesigned app and four panel sizes arrive just in time for the
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
MACOM Q4'26 EPS estimate is 2.00 USD
MACOM is scheduled to report Q4'26 results on November 05 before the market opens. Revenue is estimated at 420.38 million USD.
EQUITY | Nov 04, 2026, 12:02 PM UTC
L
Olympus Cosmetic Group to Deploy AI Med Consult Across Its Practices
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
RGA Q3'26 Earnings Preview
Reinsurance Group of America is scheduled to report Q3'26 results on November 5 after the market closes. Revenue and EPS estimates were provided.
EQUITY | Nov 04, 2026, 12:02 PM UTC
M
RDCM Q3'26 Revenue Estimate Ahead of Results
RDCM is scheduled to report Q3'26 results on November 11 before the market opens. Revenue and EPS estimates were provided.
EQUITY | Nov 04, 2026, 12:02 PM UTC